No effects on morphological enhancement were being noticed in embryo-fetal progress reports with oral administration of methylphenidate to pregnant rats and rabbits in the course of organogenesis at doses approximately 10 and fifteen times, respectively, the utmost suggested human dose (MRHD) of sixty mg/working day supplied to adolescents on the m